ArticleScientific reports2025

CRISPR/dCas9-TET1-mediated epigenetic editing reactivates miR-200c in breast cancer cells.

Mahyar Zahraei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.